Mohammed A Khan

Title: Innovations of Mohammed A Khan

Introduction

Mohammed A Khan is a notable inventor based in Morgan Hill, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bradykinin antagonists. With a total of 2 patents, his work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Khan's latest patents include innovative compounds known as sulfonylquinoxalone derivatives. These compounds are disclosed as useful bradykinin antagonists, which can play a crucial role in managing conditions associated with bradykinin activity. The specific derivatives he has developed are sulfonylquinoxalone acetamide derivatives, which are designed to target and inhibit bradykinin effectively.

Career Highlights

Currently, Mohammed A Khan is associated with Elan Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His expertise in medicinal chemistry and pharmacology has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Khan has collaborated with several professionals in his field, including Francine S Grant and Sarah Bartulis. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of his patented compounds.

Conclusion

In summary, Mohammed A Khan is a distinguished inventor whose work in developing bradykinin antagonists has the potential to make a significant impact in the pharmaceutical industry. His contributions reflect a commitment to advancing medical science and improving patient outcomes.